Response

Overview

Journal Chest

Publisher Elsevier

Specialty Pulmonary Medicine

Date 2017 Jul 12

PMID 28693772

Authors

Robert A Balk

Sameer S Kadri

Zhun Cao

Scott B Robinson

Craig Lipkin

Samuel A Bozzette

Affiliations

Soon will be listed here.

References

Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer R . Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017; 45(3):486-552. DOI: 10.1097/CCM.0000000000002255. View

Prkno A, Wacker C, Brunkhorst F, Schlattmann P . Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis. Crit Care. 2013; 17(6):R291. PMC: 4056085. DOI: 10.1186/cc13157. View

de Jong E, van Oers J, Beishuizen A, Vos P, Vermeijden W, Haas L . Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016; 16(7):819-827. DOI: 10.1016/S1473-3099(16)00053-0. View

Balk R, Kadri S, Cao Z, Robinson S, Lipkin C, Bozzette S . Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States. Chest. 2016; 151(1):23-33. PMC: 6026224. DOI: 10.1016/j.chest.2016.06.046. View

Kumar A, Roberts D, Wood K, Light B, Parrillo J, Sharma S . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34(6):1589-96. DOI: 10.1097/01.CCM.0000217961.75225.E9. View